Can we replace first line targeted therapy with immune therapy in renal cancer?

Date 09 December 2017
Event ESMO Immuno-Oncology Congress 2017
Session What’s new in genitourinary (GU) tumours
Topics Anticancer Agents
Bioethics, Legal, and Economic Issues
Prostate Cancer
Genitourinary Cancers
Biological Therapy
Presenter Laurence Albiges
Authors L. Albiges
  • Medical Oncology, Institut Gustave Roussy, 94805 - Villejuif/FR